Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia [Phase 2]
A Phase 2 trial evaluating arsenic trioxide for relapsed or refractory acute lymphoblastic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy in patients with acute lymphoblastic leukemia or non-Hodgkin lymphoma. The stud…
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia [Phase 3]
A Phase 3 trial comparing chemotherapy with or without bone marrow transplantation in patients with acute lymphoblastic leukemia has complet…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial evaluating rituximab in combination with interleukin-2 in various hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma [Phase 3]
A Phase 3 trial evaluating a combination chemotherapy regimen for pediatric patients with acute lymphoblastic leukemia or advanced lymphobla…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 clinical trial evaluating alemtuzumab with or without methotrexate and mercaptopurine for relapsed acute lymphoblastic leukemia in y…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia [Phase 1]
Phase 1 clinical trial evaluating safety and dosing of 17-N-allylamino-17-demethoxygeldanamycin (tanespimycin) in pediatric patients with re…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors [Phase 1]
Completed Phase 1 trial evaluating tanespimycin in pediatric patients with recurrent or refractory leukemia or solid tumors.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating the combination of tanespimycin (17-allylamino-17-demethoxygeldanamycin) and bortezomib in relapsed or ref…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
A Phase 1 clinical trial of flavopiridol (alvocidib) in relapsed or refractory acute myeloid leukemia, acute lymphoblastic leukemia, or chro…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial of a monoclonal antibody therapy in patients with chronic lymphocytic leukemia, small lymphocytic lymphoma, acute lym…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia [Phase 3]
Phase 3 trial evaluating risk-adapted combination chemotherapy for young patients with acute lymphoblastic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders [Phase 1]
Phase 1 study evaluating a combination of vorinostat, cytarabine, and etoposide in patients with relapsed or refractory acute leukemia, myel…
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: Treatment of Acute Lymphoblastic Leukemia in Children [Phase 3]
Phase 3 clinical trial update for treatment of acute lymphoblastic leukemia in children; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Endothelial Function, Arterial Stiffness and Components
This clinical trial update reports on a completed study evaluating endothelial function and arterial stiffness in patients with Acute Lympho…
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation [NA]
This clinical trial evaluated deferoxamine to manage iron overload before allogeneic stem cell transplantation in patients with acute myeloi…
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia [Phase 1]
Phase 1 trial evaluating flavopiridol and vorinostat in relapsed or refractory acute leukemias and related myeloid disorders has completed e…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 trial updating the use of Imatinib Mesylate with combination chemotherapy, with or without donor stem cell transplant, in newly diag…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+) [Phase 2]
Phase 2 trial of imatinib mesylate in children with Philadelphia chromosome-positive acute lymphoblastic leukemia has been suspended.
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies [Phase 3]
Phase 3 study evaluating methotrexate or pentostatin for graft-versus-host disease prophylaxis in risk-adapted allogeneic bone marrow transp…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma [Phase 2]
This Phase 2 trial update reports the outcomes of a combination chemotherapy regimen in children with acute lymphoblastic leukemia, osteosar…
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluated the combination of clofarabine and cyclophosphamide in patients with acute lymphoblastic leukemia…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Observational Study of Iron Overload in Stem Cell Transplantation
This clinical trial update notes the completion of an observational study on iron overload in stem cell transplantation involving patients w…
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia [Phase 3]
Phase 3 trial comparing two asparaginase preparations in children with previously untreated acute lymphoblastic leukemia to assess efficacy …
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Stem Cell Transplantation for Hematological Malignancies [Phase 2, Phase 3]
This clinical trial update reports termination of a Phase 2/Phase 3 study evaluating stem cell transplantation for hematologic malignancies.…